JPWO2022114031A1 - - Google Patents

Info

Publication number
JPWO2022114031A1
JPWO2022114031A1 JP2022565391A JP2022565391A JPWO2022114031A1 JP WO2022114031 A1 JPWO2022114031 A1 JP WO2022114031A1 JP 2022565391 A JP2022565391 A JP 2022565391A JP 2022565391 A JP2022565391 A JP 2022565391A JP WO2022114031 A1 JPWO2022114031 A1 JP WO2022114031A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022565391A
Other languages
Japanese (ja)
Other versions
JPWO2022114031A5 (https=
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2022114031A1 publication Critical patent/JPWO2022114031A1/ja
Publication of JPWO2022114031A5 publication Critical patent/JPWO2022114031A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4005—Concentrating samples by transferring a selected component through a membrane
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150015—Source of blood
    • A61B5/150022—Source of blood for capillary blood or interstitial fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150305—Packages specially adapted for piercing devices or blood sampling devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150358—Strips for collecting blood, e.g. absorbent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/150007—Details
    • A61B5/150801—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
    • A61B5/150824—Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by visual feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/15—Devices for taking samples of blood
    • A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4044—Concentrating samples by chemical techniques; Digestion; Chemical decomposition
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00—Sampling; Preparing specimens for investigation
    • G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/40—Concentrating samples
    • G01N1/4005—Concentrating samples by transferring a selected component through a membrane
    • G01N2001/4016—Concentrating samples by transferring a selected component through a membrane being a selective membrane, e.g. dialysis or osmosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
    • G01N2333/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38—Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Manufacturing & Machinery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2022565391A 2020-11-25 2021-11-24 Pending JPWO2022114031A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020195592 2020-11-25
PCT/JP2021/043076 WO2022114031A1 (ja) 2020-11-25 2021-11-24 血漿又は血清を分離し保管するための媒体、それを製造する方法、デバイス、キット、及び糖化タンパク質の測定方法

Publications (2)

Publication Number Publication Date
JPWO2022114031A1 true JPWO2022114031A1 (https=) 2022-06-02
JPWO2022114031A5 JPWO2022114031A5 (https=) 2024-11-27

Family

ID=81755570

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022565391A Pending JPWO2022114031A1 (https=) 2020-11-25 2021-11-24

Country Status (5)

Country Link
US (1) US12523582B2 (https=)
EP (1) EP4253953A4 (https=)
JP (1) JPWO2022114031A1 (https=)
CN (1) CN116438435A (https=)
WO (1) WO2022114031A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2024117063A1 (https=) * 2022-11-30 2024-06-06

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09166597A (ja) * 1995-08-24 1997-06-24 Boehringer Mannheim Gmbh マトリックス物質上の試料のグリコタンパク質含量を安定化するための方法
JPH10104226A (ja) * 1996-09-30 1998-04-24 Masaki Kobayashi 血液検体採集カード
JPH10206298A (ja) * 1996-12-03 1998-08-07 Boehringer Mannheim Gmbh サンプル物質の保管および移送システム
JP2003270238A (ja) * 2002-03-14 2003-09-25 Sanyo Chem Ind Ltd 体液検査用具
WO2004083852A1 (ja) * 2003-03-10 2004-09-30 Arkray Inc. 血球分離膜およびこれを用いた血液保持用具
WO2016158733A1 (ja) * 2015-03-27 2016-10-06 株式会社Ｌｓｉメディエンス 採血用絆創膏
WO2018066167A1 (ja) * 2016-10-03 2018-04-12 セルスペクト株式会社 血漿分離装置及び血漿分離方法
WO2018089315A1 (en) * 2016-11-08 2018-05-17 Reliant Immune Diagnostics, LLC System and method for image analysis of medical test results
JP2018513363A (ja) * 2015-03-31 2018-05-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血漿分離カード

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551004A1 (de) * 1975-11-13 1977-05-26 Owens Illinois Inc Glukoseanalyse
JPH0630791A (ja) 1992-05-20 1994-02-08 Shionogi & Co Ltd 糖化蛋白の定量方法
DK0832430T3 (da) 1995-05-09 2006-11-20 Beckman Coulter Inc Anordninger og metoder til at separere cellulære blodkomponenter fra den flydende del af blodet
JP2001221794A (ja) 1999-12-01 2001-08-17 Srl Inc 血清分離シートを使用した血液検体の生化学的検査
JP2002022724A (ja) 2000-07-04 2002-01-23 Toshihiko Hanai 糖化アルブミンの迅速分析方法
US6951728B2 (en) * 2002-05-10 2005-10-04 Lifescan, Inc. Multilayer reagent test strips to quantify glycated protein in a physiological sample
JP2006133143A (ja) 2004-11-08 2006-05-25 Japan Vilene Co Ltd 血漿又は血清の保持材及び血液分離用具
US20060270060A1 (en) * 2005-05-31 2006-11-30 Smith Henry J Rapid test for glycated albumin in saliva
PL1982182T3 (pl) * 2006-01-19 2012-09-28 Lattec I/S Nowa konstrukcja przyrządu w postaci suchego paska oraz sposób oznaczania analitu w próbce przy użyciu przyrządu w postaci suchego paska
JP4301523B2 (ja) 2006-04-24 2009-07-22 旭化成ファーマ株式会社 糖化タンパク質割合測定方法
TWI532468B (zh) * 2011-03-22 2016-05-11 福 赫夫曼 拉瑞奇股份有限公司 具有含矽石結構奈米粒子之親水性塗層的分析輔助器具
JP6121400B2 (ja) * 2011-04-29 2017-04-26 セブンス センス バイオシステムズ，インコーポレーテッド 流体の送達および／または受け取り
BR112014018970A8 (pt) * 2012-02-02 2017-07-11 Becton Dickinson Co Dispositivos de coleta de amostra com agentes de estabilização sanguínea
EP3046550B1 (en) * 2013-09-17 2020-04-15 The Regents of the University of California Enzyme-encapsulated nanoparticle platform
FR3012972A1 (fr) * 2013-11-14 2015-05-15 Biomerieux Sa Nouveau milieu filtrant pour l'obtention de plasma, dispositif et procede de filtration associes
US11561165B2 (en) * 2016-02-11 2023-01-24 Tascom Co., Ltd. Biometric system
WO2020037269A2 (en) * 2018-08-17 2020-02-20 The Regents Of The University Of California Composite matrix for analyte biosensors
CN115397977A (zh) * 2020-03-06 2022-11-25 索鲁根公司 用于生产葡萄糖氧化产物的组合物和方法

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09166597A (ja) * 1995-08-24 1997-06-24 Boehringer Mannheim Gmbh マトリックス物質上の試料のグリコタンパク質含量を安定化するための方法
JPH10104226A (ja) * 1996-09-30 1998-04-24 Masaki Kobayashi 血液検体採集カード
JPH10206298A (ja) * 1996-12-03 1998-08-07 Boehringer Mannheim Gmbh サンプル物質の保管および移送システム
JP2003270238A (ja) * 2002-03-14 2003-09-25 Sanyo Chem Ind Ltd 体液検査用具
WO2004083852A1 (ja) * 2003-03-10 2004-09-30 Arkray Inc. 血球分離膜およびこれを用いた血液保持用具
WO2016158733A1 (ja) * 2015-03-27 2016-10-06 株式会社Ｌｓｉメディエンス 採血用絆創膏
JP2018513363A (ja) * 2015-03-31 2018-05-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 血漿分離カード
WO2018066167A1 (ja) * 2016-10-03 2018-04-12 セルスペクト株式会社 血漿分離装置及び血漿分離方法
WO2018089315A1 (en) * 2016-11-08 2018-05-17 Reliant Immune Diagnostics, LLC System and method for image analysis of medical test results

Also Published As

Publication number Publication date
US12523582B2 (en) 2026-01-13
CN116438435A (zh) 2023-07-14
WO2022114031A1 (ja) 2022-06-02
EP4253953A1 (en) 2023-10-04
EP4253953A4 (en) 2024-09-25
US20240027313A1 (en) 2024-01-25

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20241119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20251217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260205

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260413

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260420